4503

COM:ASTELLAS

Astellas Pharma Inc.

  • Stock

JPY

Last Close

1,562.00

25/11 06:45

Market Cap

2.98T

Beta: -

Volume Today

14.54M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
1.14T
-
1.25T
9.42%
1.37T
10.06%
1.31T
4.45%
1.30T
0.87%
1.31T
0.46%
1.31T
0%
1.25T
4.35%
1.30T
3.73%
1.30T
0%
1.60T
23.72%
cost of revenue
330.63B
-
333.20B
0.78%
335.60B
0.72%
320.50B
4.50%
294.25B
8.19%
292.05B
0.75%
292.05B
0%
246.06B
15.75%
253.01B
2.82%
253.01B
0%
391.31B
54.66%
gross profit
809.28B
-
914.06B
12.95%
1.04T
13.46%
991.16B
4.43%
1.01T
1.50%
1.01T
0.82%
1.01T
0%
1.00T
1.07%
1.04T
3.96%
1.04T
0%
1.21T
16.22%
selling and marketing expenses
general and administrative expenses
397.02B
-
452.52B
13.98%
500.36B
10.57%
470.78B
5.91%
478.33B
1.60%
490.26B
2.49%
490.26B
0%
504.32B
2.87%
548.84B
8.83%
548.84B
0%
selling general and administrative expenses
397.02B
-
452.52B
13.98%
500.36B
10.57%
470.78B
5.91%
478.33B
1.60%
490.26B
2.49%
490.26B
0%
504.32B
2.87%
548.84B
8.83%
548.84B
0%
740.11B
34.85%
research and development expenses
191.46B
-
206.59B
7.90%
225.66B
9.23%
208.13B
7.77%
220.78B
6.08%
208.68B
5.48%
208.68B
0%
224.49B
7.57%
246.01B
9.59%
246.01B
0%
294.19B
19.58%
other expenses
105.45B
-
69.50B
34.09%
60.86B
12.44%
49.56B
18.56%
91.28B
84.17%
69.81B
23.51%
69.81B
0%
139.09B
99.22%
117.34B
15.63%
117.34B
0%
cost and expenses
1.02T
-
1.06T
3.64%
1.12T
5.71%
1.05T
6.55%
1.08T
3.40%
1.06T
2.20%
1.06T
0%
1.11T
5.01%
1.17T
4.60%
1.17T
0%
1.43T
22.35%
operating expenses
693.92B
-
728.62B
5.00%
786.88B
8.00%
728.47B
7.42%
790.39B
8.50%
768.76B
2.74%
768.76B
0%
867.89B
12.90%
912.19B
5.10%
912.19B
0%
1.03T
13.39%
interest expense
1.66B
-
3.08B
85.65%
1.63B
47.14%
1.98B
21.45%
1.78B
9.82%
1.30B
26.94%
1.30B
0%
2.33B
79.34%
4.95B
111.95%
4.95B
0%
12.01B
142.57%
ebitda
187.94B
-
258.24B
37.41%
332.58B
28.79%
347.54B
4.50%
284.76B
18.06%
313.73B
10.17%
313.73B
0%
220.31B
29.78%
217.28B
1.37%
217.28B
0%
335.91B
54.59%
operating income
116.81B
-
185.66B
58.95%
248.99B
34.11%
260.83B
4.76%
213.26B
18.24%
243.91B
14.37%
243.91B
0%
136.05B
44.22%
155.69B
14.43%
155.69B
0%
178.07B
14.38%
depreciation and amortization
64.30B
-
65.47B
1.82%
69.19B
5.67%
63.79B
7.80%
64.86B
1.68%
63.46B
2.17%
63.46B
0%
72.65B
14.49%
79.68B
9.68%
61.60B
22.70%
157.84B
156.24%
total other income expenses net
6.62B
-
4.24B
35.99%
11.54B
172.39%
19.07B
65.27%
2.44B
87.23%
-33.45B
1,473.68%
3.43B
110.25%
-105.61B
3,180.78%
-61.26B
41.99%
1.20B
101.96%
-149.94B
12,594.67%
income before tax
121.97B
-
189.68B
55.51%
261.77B
38.00%
281.77B
7.64%
218.11B
22.59%
248.97B
14.15%
248.97B
0%
145.32B
41.63%
156.89B
7.96%
156.89B
0%
28.13B
82.07%
income tax expense
31.10B
-
53.83B
73.08%
68.08B
26.48%
63.07B
7.36%
53.43B
15.28%
26.70B
50.03%
26.70B
0%
24.73B
7.37%
32.80B
32.61%
32.80B
0%
7.92B
75.84%
net income
90.87B
-
135.86B
49.50%
193.69B
42.57%
218.70B
12.91%
164.68B
24.70%
222.26B
34.97%
195.41B
12.08%
120.59B
38.29%
124.09B
2.90%
98.71B
20.45%
17.05B
82.73%
weighted average shs out
2.25B
-
2.21B
1.67%
2.16B
2.31%
2.11B
2.27%
2.03B
3.74%
1.93B
4.84%
1.93B
0%
1.86B
3.87%
1.85B
0.40%
1.85B
0%
1.79B
3.05%
weighted average shs out dil
2.25B
-
2.21B
1.66%
2.16B
2.31%
2.11B
2.28%
2.03B
3.76%
1.93B
4.86%
1.93B
0%
1.86B
3.91%
1.85B
0.41%
1.85B
0%
1.80B
2.75%
eps
40.45
-
61.50
52.04%
89.75
45.93%
103.69
15.53%
81.11
21.78%
115.05
41.84%
115.05
0%
64.93
43.56%
67.08
3.31%
67.08
0%
9.50
85.84%
epsdiluted
40.39
-
61.40
52.02%
89.62
45.96%
103.55
15.54%
81.02
21.76%
114.94
41.87%
114.94
0%
64.90
43.54%
67.05
3.31%
67.05
0%
9.47
85.88%

All numbers in JPY (except ratios and percentages)